Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Hinz

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Plos One|September 28, 2022
Intergenerational wealth transmission and homeownership in Europe-a comparative perspectiveOr Cohen Raviv, Thomas Hinz
Pharmazie in Unserer Zeit|December 18, 2007
[Trends in vaccine development]Jürgen Scherer, Thomas Hinz, Klaus Cichutek
Critical Reviews in Immunology|November 4, 2019
RNA-Based Adjuvants: Immunoenhancing Effect on Antiviral Vaccines and Regulatory ConsiderationsAnnett Ziegler, Thomas Hinz, Ulrich Kalinke
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|September 10, 2015
[Tumor vaccines and peptide-loaded dendritic cells (DCs)]Verena Schummer, Sven Flindt, Thomas Hinz
Plos One|July 20, 2023
Media coverage, fake news, and the diffusion of xenophobic violence: A fine-grained county-level analysis of the geographic and temporal patterns of arson attacks during the German refugee crisis 2015-2017Thomas Hinz, Sandra Walzenbach, Johannes Laufer, et al.
Gene|August 19, 2004
A CpG-rich bidirectional promoter induces the T-cell death-associated gene 51 and downregulates an inversely oriented transcript during early T-cell activationMarc Meier-Noorden, Sven Flindt, Ulrich Kalinke, et al.
The British Journal of Sociology|January 31, 2025
Fairness Evaluations of Higher Education Graduates' Earnings: The Role of Female Preference for Equality and Self-InterestAnna Zamberlan, Diana Roxana Galos, Susanne Strauß, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 9, 2020
[Therapeutic vaccination for tumors and neurodegenerative diseases]Verena Scheer, Mark Goldammer, Sven Flindt, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 15, 2006
Manufacturing and quality control of cell-based tumor vaccines: a scientific and a regulatory perspectiveThomas Hinz, Christian J Buchholz, Ton van der Stappen, et al.
BMC Public Health|July 23, 2021
Sports participation of children and adolescents in Germany: disentangling the influence of parental socioeconomic statusLea Rittsteiger, Thomas Hinz, Doris Oriwol, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Plos One|September 28, 2022
Intergenerational wealth transmission and homeownership in Europe-a comparative perspectiveOr Cohen Raviv, Thomas Hinz
Pharmazie in Unserer Zeit|December 18, 2007
[Trends in vaccine development]Jürgen Scherer, Thomas Hinz, Klaus Cichutek
Critical Reviews in Immunology|November 4, 2019
RNA-Based Adjuvants: Immunoenhancing Effect on Antiviral Vaccines and Regulatory ConsiderationsAnnett Ziegler, Thomas Hinz, Ulrich Kalinke
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|September 10, 2015
[Tumor vaccines and peptide-loaded dendritic cells (DCs)]Verena Schummer, Sven Flindt, Thomas Hinz
Plos One|July 20, 2023
Media coverage, fake news, and the diffusion of xenophobic violence: A fine-grained county-level analysis of the geographic and temporal patterns of arson attacks during the German refugee crisis 2015-2017Thomas Hinz, Sandra Walzenbach, Johannes Laufer, et al.
Gene|August 19, 2004
A CpG-rich bidirectional promoter induces the T-cell death-associated gene 51 and downregulates an inversely oriented transcript during early T-cell activationMarc Meier-Noorden, Sven Flindt, Ulrich Kalinke, et al.
The British Journal of Sociology|January 31, 2025
Fairness Evaluations of Higher Education Graduates' Earnings: The Role of Female Preference for Equality and Self-InterestAnna Zamberlan, Diana Roxana Galos, Susanne Strauß, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 9, 2020
[Therapeutic vaccination for tumors and neurodegenerative diseases]Verena Scheer, Mark Goldammer, Sven Flindt, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 15, 2006
Manufacturing and quality control of cell-based tumor vaccines: a scientific and a regulatory perspectiveThomas Hinz, Christian J Buchholz, Ton van der Stappen, et al.
BMC Public Health|July 23, 2021
Sports participation of children and adolescents in Germany: disentangling the influence of parental socioeconomic statusLea Rittsteiger, Thomas Hinz, Doris Oriwol, et al.
Pageof 2